
doc.ai is developing A.I. technologies to collect structured and real-world medical data to create engaging products, accelerate medical research and transform approaches to care. Their poly-omics data pipeline handles all forms of medical data to make it ready for analysis and model building. The company's primary consumer offering is a medical research companion app for personal-omics collection and digital health trials where participants can earn financial rewards. Additionally, they license A.I. modules and create products for a portfolio of clients, including payors, pharma, providers and patient organizations.

doc.ai is developing A.I. technologies to collect structured and real-world medical data to create engaging products, accelerate medical research and transform approaches to care. Their poly-omics data pipeline handles all forms of medical data to make it ready for analysis and model building. The company's primary consumer offering is a medical research companion app for personal-omics collection and digital health trials where participants can earn financial rewards. Additionally, they license A.I. modules and create products for a portfolio of clients, including payors, pharma, providers and patient organizations.
Founded: 2016
Headquarters: Palo Alto, California
Business focus: AI-driven digital health, personal-omics data capture and analysis
Total funding (reported): USD 43,300,000
Making heterogeneous medical and real-world data usable for analysis and AI model building to support research and care.
2016
Digital health / AI
“Pantera Capital; David J. Namdar”